Literature DB >> 8649992

A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo.

J Chen1, R Peters, P Saha, P Lee, A Theodoras, M Pagano, G Wagner, A Dutta.   

Abstract

The cell cycle regulator p21 interacts with and inhibits the DNA replication and repair factor proliferating cell nuclear antigen (PCNA). We have defined a 39 amino acid fragment of p21 which is sufficient to bind PCNA with high affinity (Kd 10-20 nM). This peptide can inhibit DNA replication in vitro and microinjection of a GST fusion protein containing this domain inhibited S phase in vivo. Despite its high affinity for PCNA, the free 39 amino acid peptide does not have a well-defined structure, as judged from circular dichroism and nuclear magnetic resonance measurements, suggesting an induced fit mechanism for the PCNA-p21 interaction. The association of the small peptide with PCNA was thermolabile, suggesting that portions of p21 adjoining the minimal region of contact stabilize the interaction. In addition, a domain containing 67 amino acids from the N-terminus of PCNA was defined as both necessary and sufficient for binding to p21.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649992      PMCID: PMC145832          DOI: 10.1093/nar/24.9.1727

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  SH2 domains recognize specific phosphopeptide sequences.

Authors:  Z Songyang; S E Shoelson; M Chaudhuri; G Gish; T Pawson; W G Haser; F King; T Roberts; S Ratnofsky; R J Lechleider
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

2.  Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair.

Authors:  M K Shivji; S J Grey; U P Strausfeld; R D Wood; J J Blow
Journal:  Curr Biol       Date:  1994-12-01       Impact factor: 10.834

3.  Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

4.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

5.  Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach.

Authors:  G Panayotou; G Gish; P End; O Truong; I Gout; R Dhand; M J Fry; I Hiles; T Pawson; M D Waterfield
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.

Authors:  V N Podust; L M Podust; F Goubin; B Ducommun; U Hübscher
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

7.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

Authors:  J Chen; P K Jackson; M W Kirschner; A Dutta
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

8.  A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.

Authors:  E Warbrick; D P Lane; D M Glover; L S Cox
Journal:  Curr Biol       Date:  1995-03-01       Impact factor: 10.834

9.  Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.

Authors:  F Goubin; B Ducommun
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

View more
  14 in total

1.  Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Authors:  Z Sever-Chroneos; S P Angus; A F Fribourg; H Wan; I Todorov; K E Knudsen; E S Knudsen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 2.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

3.  Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cells.

Authors:  Hong Shen; Carl G Maki
Journal:  J Biol Chem       Date:  2010-05-20       Impact factor: 5.157

4.  p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex.

Authors:  U Chen; S Chen; P Saha; A Dutta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo.

Authors:  M P Cooper; A S Balajee; V A Bohr
Journal:  Mol Biol Cell       Date:  1999-07       Impact factor: 4.138

6.  Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.

Authors:  Bipin C Dash; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design.

Authors:  George Kontopidis; Su-Ying Wu; Daniella I Zheleva; Paul Taylor; Campbell McInnes; David P Lane; Peter M Fischer; Malcolm D Walkinshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-28       Impact factor: 11.205

8.  The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1.

Authors:  Wensheng Wang; Patrick Brandt; Marie L Rossi; Laura Lindsey-Boltz; Vladimir Podust; Ellen Fanning; Aziz Sancar; Robert A Bambara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

9.  REGγ is a strong candidate for the regulation of cell cycle, proliferation and the invasion by poorly differentiated thyroid carcinoma cells.

Authors:  M Zhang; L Gan; G S Ren
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

10.  Proliferating cell nuclear antigen (PCNA) interactions in solution studied by NMR.

Authors:  Alfredo De Biasio; Ramón Campos-Olivas; Ricardo Sánchez; Jorge P López-Alonso; David Pantoja-Uceda; Nekane Merino; Maider Villate; Jose M Martin-Garcia; Francisco Castillo; Irene Luque; Francisco J Blanco
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.